Brisbane Biotech Showcases Degrader Pipeline Advantages at AACR
Research Report
Co. in Bolivia Doubles Tin Resource and Adds High-Grade Indicated Core at Iska Iska
Research Report
Asceniv Growth, Margin Expansion, and Pipeline Optionality Drive Price Target
Research Report
Counterdrone Co.'s FIFA World Cup Order, $155M Committed Revenue, and C-UAS Industry Tailwinds Drive Buy Rating
Research Report
Silver Royalty Co. Hits Cash Flow Inflection Point as PPX Igor 4 Minimum Payments Begin
Research Report
Contango Ore Merger With Dolly Varden Approved: Combined Cash Tops US$112M
Research Report
Company Wins Back Promising Eye Disease Drug and Eyes Two Product Launches by 2028
Research Report
Orca Energy Group Rated Hold: Tanzania Exit and Capital Return Strategy Signal Major Strategic Shift
Research Report
Research Capital maintained a Hold rating on Orca Energy Group Inc. (ORC.B:TSXV; ORXGF:OTCMKTS), following the company's agreement to sell its Tanzanian Songo Songo business for nominal consideration. CarMax Targets Costs as Used Car Prices and Loan Income Face Pressure in 2027
Research Report
RBC Capital Markets reviewed CarMax's F4Q'26 results, highlighting an expanded US$200M SG&A reduction target, retail GPU compression heading into FY2027, and declining CAF income. The Company Quietly Powering Next-Generation AI Chips
Research Report
ROTH Capital Partners reiterated its rating on Adeia Inc. (ADEA:NASDAQ), citing accelerating hybrid bonding adoption in logic chiplets (AMD, Broadcom), 3D NAND (Kioxia, Sandisk), and HBM4e DRAM. MA Biotech Co. Downgraded to Sell After Second FDA CRL for RP-1 Melanoma BLA
Research Report
H.C. Wainwright downgraded Replimune Group (REPL:NASDAQ) to Sell after the FDA issued a second Complete Response Letter for the RP-1 plus Opdivo BLA in anti-PD1 failed melanoma. Energy Co. Has Strong Flow Test in Uzbekistan
Research Report
Condor Energies Inc. (CDR:TSX.V) reported a strong flow test at the K-46 horizontal well in Uzbekistan, according to an Auctus Advisors research note. Canadian Gold Co. Secures Full Mill Circuit, Targets May 2026 Drilling
Research Report
ESGold Corp. (ESAU:CSE; ESAUF:OTCQB; Z7D:FSE) secured all major mill components for its Montauban Gold-Silver Project and advanced drill permits, with first production on track for H2 2026 and drilling set to begin in May, as reported by an Atrium Research note. AI-Native Digital Banking Partnership Could Transform FTRC's Revenue Model
Research Report
The FUTR Corp. (FTRC:TSX; FTRCF:OTC; QA20:FSE) announced a proposed joint venture with global neobank EQIBank, a deal that could shift FUTR from a single-product fintech into a multi-stream AI-driven financial platform with over 1,600% upside potential to target, according to a Research Capital note. Lucky Strike Zone Poised to Exceed Sullivan, Water Rights Secured
Research Report
P2 Gold Inc. (PGLD:TSXV) is expanding Lucky Strike drilling results and a key water rights acquisition that de-risks the Gabbs Project ahead of Q4-2026 feasibility, noted a Couloir Capital report. San Francisco Pharma Co.'s HORIZON Phase 2 Data Validates APOL1 Path to Pivotal Trial
Research Report
H.C. Wainwright reiterated its rating and price target on Maze Therapeutics (MAZE:NASDAQ), following KOL calls that validated the HORIZON Phase 2 dataset as biologically coherent, confirmed the diabetic cohort signal as drug-attributable proof of concept, and outlined a clear path to pivotal trials. 
Streetwise Key Charts
